| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc. (GH) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. GH is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.03M | $261.30M | -100,000 | |
| Other | 79.1K | $10.19M | - | |
| CFO | 47.5K | $6.12M | -2,000 | |
| Other | 46.7K | $6.02M | - | |
| Other | 36.0K | $4.63M | -10,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 150,000 | $158.39 | $23,758,873.42 | -4.2% | |
| Jan 11, 2021 | Meresman Stanley J75 | Director | Sale+OE | 4,934 | $142.00 | $700,628.00 | -54.9% | |
| Jan 4, 2021 | Clark Ian T66 | Director | Sale+OE | 2,690 | $129.23 | $347,628.70 | -36.7% | |
| Dec 28, 2020 | Clark Ian T66 | Director | Sale+OE | 538 | $135.00 | $72,630.00 | -10.4% | |
| Dec 10, 2020 | Meresman Stanley J75 | Director | Sale+OE | 4,954 | $125.44 | $621,429.76 | -55.0% | |
| Dec 3, 2020 | Clark Ian T66 | Director | Sale+OE | 2,690 | $120.00 | $322,800.00 | -36.7% | |
| Nov 25, 2020 | Clark Ian T66 | Director | Sale+OE | 538 | $113.28 | $60,944.64 | -10.4% | |
| Nov 10, 2020 | Meresman Stanley J75 | Director | Sale+OE | 5,000 | $110.30 | $551,500.00 | -55.2% | |
| Nov 3, 2020 | Clark Ian T66 | Director | Sale+OE | 2,690 | $105.28 | $283,203.20 | -36.7% | |
| Oct 27, 2020 | Talasaz Amirali | Chairman, President And COO | Sell | 93,600 | $106.79 | $9,995,328.67 | -1.7% |